NEW JERSEY UROLOGY EXCELLENCE IN CARE
Live / Registered — Registered (as of 18 Apr 2023)
What this means for you
Registered since 18 Apr 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90888809
- Registration number
- 7028569
- Mark type
- Design + words
- Filed
- 18 Aug 2021
- Published for opposition
- 31 Jan 2023
- Registered
- 18 Apr 2023
- Attorney of record
- Mari-Elise Paul
Goods and services
- Class 042 — Scientific and technological services: Clinical research in the fields of urology, urogynecology, and oncology
- Class 044 — Medical, beauty and agricultural services: Health care services, namely, urology medical care services, oncology medical care services, and urogynecology medical care services; health care services being medical care treatment services in the field of urology; urogynecology medical care and treatment services; surgical services, namely, performing surgeries for medical treatment purposes; medical diagnosis and treatment of cancer; medical oncology, namely, health care services for treating cancer
Owner
- New Jersey Urology, LLC, Bloomfield, NJ, US
- New Jersey Urology, LLC, Bloomfield, NJ, US
- New Jersey Urology, LLC, Bloomfield, NJ, US
Prosecution history
- 18 Apr 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Apr 2023 — REGISTERED-PRINCIPAL REGISTER
- 08 Feb 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 31 Jan 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Jan 2023 — PUBLISHED FOR OPPOSITION
- 11 Jan 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Dec 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Dec 2022 — EXAMINER'S AMENDMENT ENTERED
- 01 Dec 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 01 Dec 2022 — EXAMINERS AMENDMENT E-MAILED
- 01 Dec 2022 — EXAMINERS AMENDMENT -WRITTEN
- 29 Nov 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 28 Nov 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 28 Nov 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 May 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED